Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Phathom Pharmaceuticals Inc
(NQ:
PHAT
)
13.84
+1.03 (+8.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Phathom Pharmaceuticals Inc
< Previous
1
2
3
4
Next >
These Are The Top 3 Most-Shorted Stocks In August 2024; Here’s Why
August 21, 2024
Short-squeeze opportunities are tough to find. Combine market timing with fundamentals for these stocks.
Via
Talk Markets
PHAT Stock Earnings: Phathom Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
PHAT stock results show that Phathom Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Ready for Quick Gains? 7 Top Short-Squeeze Stocks to Watch Now
June 09, 2024
Each of the following seven heavily-shorted stocks may have what it takes to become one of the next big short squeeze stocks.
Via
InvestorPlace
Ride the Gamma Wave: 3 Stocks on the Verge of a Short Squeeze
June 07, 2024
Though short squeezes are never guaranteed, these three potential short squeeze stocks could provide generous returns if bought right.
Via
InvestorPlace
The 3 Best Healthcare Stocks to Buy in May 2024
May 10, 2024
Healthcare firms can make large amounts of money, particularly in the U.S. Here are the three best healthcare stocks to buy now.
Via
InvestorPlace
Preview: Phathom Pharmaceuticals's Earnings
March 06, 2024
Via
Benzinga
Recap: Phathom Pharmaceuticals Q3 Earnings
November 09, 2023
Via
Benzinga
Phathom Pharmaceuticals Resubmits FDA Application For Acid Blocker, Raises $131M Via Equity
May 24, 2023
Via
Benzinga
Analyst Expectations for Phathom Pharmaceuticals's Future
May 11, 2023
Via
Benzinga
PHAT Stock Earnings: Phathom Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024
May 09, 2024
PHAT stock results show that Phathom Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
PHAT Stock Earnings: Phathom Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023
March 07, 2024
PHAT stock results show that Phathom Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
February 20, 2024
U.S. stocks were mostly lower, with the Nasdaq Composite falling more than 200 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
February 19, 2024
Via
Benzinga
Where Phathom Pharmaceuticals Stands With Analysts
April 05, 2023
Via
Benzinga
Where Phathom Pharmaceuticals Stands With Analysts
March 13, 2023
Via
Benzinga
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 16, 2024
Via
Benzinga
"Top Pick for 2024": Analyst Bullish On Phathom Pharmaceuticals On Voquezna Launch In Erosive GERD, Projecting $55.6M In Sales
January 05, 2024
Needham analyst Joseph Stringer reiterated a Buy rating on Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT),
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 01, 2023
Via
Benzinga
What's Going On With Phathom Pharmaceuticals Stock?
October 30, 2023
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) shares are trading higher Monday after the company announced FDA approval of its reformulated vo
Via
Benzinga
Exposures
Product Safety
Cramer Likes This Industrial Stock: A 'Well-Run' Company Doing 'A Lot Of Good Things'
October 13, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended not buying ChargePoint Holdings, Inc.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
August 09, 2023
Via
Benzinga
3 Cheap Biotech Stocks That Smart Investors Will Snap Up Now
August 07, 2023
One of the safest sectors on the market is biotech. Here are three cheap biotech stocks to buy that are good options for investors.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2023
May 11, 2023
Via
Benzinga
Insiders Buying Phathom Pharmaceuticals And 2 Other Stocks
April 12, 2023
Although US stocks closed mixed on Tuesday, there were a few notable insider trades.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 04, 2023
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 30, 2023
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
March 24, 2023
On Friday, 469 companies hit new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
March 13, 2023
Via
Benzinga
$14M Bet On This Technology Stock? Check Out These 4 Stocks Insiders Are Buying
February 15, 2023
Although US stocks closed mixed on Tuesday, there were a few notable insider trades.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.